Detalhe da pesquisa
1.
Membrane associated cancer-oocyte neoantigen SAS1B/ovastacin is a candidate immunotherapeutic target for uterine tumors.
Oncotarget
; 6(30): 30194-211, 2015 Oct 06.
Artigo
Inglês
| MEDLINE | ID: mdl-26327203
2.
Correction: Membrane associated cancer-oocyte neoantigen SAS1B/ovastacin is a candidate immunotherapeutic target for uterine tumors.
Oncotarget
; 8(9): 16099, 2017 02 28.
Artigo
Inglês
| MEDLINE | ID: mdl-28403580